Planning to rebrand business as Mylan to extend global brand and prepare for commercial launch of prescription products in India PITTSBURGH and MUMBAI, India, May 27, 2011 /PRNewswire/ -- Mylan Inc.
Lawmakers are imploring Mylan Pharmaceutical, the manufacturer of EpiPens, to scale back price increases that have seen the cost of the life-saving emergency allergy treatment swell from $100 to $600 ...
A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat the opioid crisis across the nation. Under the tentative settlement, Mylan ...
STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...
The lack of a cheaper version of Mylan NV’s EpiPen shot may come down to a dispute between drugmakers over a plastic cap. Unlike Mylan’s one-cap EpiPen, Teva Pharmaceutical Industries Ltd.’s proposed ...
Mylan’s life-saving EpiPen injection device is not the only medication in the company’s portfolio that has seen large price spikes, reports NBC News. In June, Wells Fargo Senior Analyst David Maris ...
Liraglutide is indicated for the treatment of insufficiently controlled type 2 diabetes. PITTSBURGH — Generic drug maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results